Delivery Order SPE2DR25D2204-SPE2DR26FS19D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,979.28 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 100 mg, a prescription opioid pain medication. This non-set-aside, competitively awarded delivery order reflects firm fixed pricing and was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.63 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a prescription opioid pain management medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 21, 2025, with an ultimate completion date of August 22, 2025. The award is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg with a ceiling value of $2,121.93. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,225.04 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 50 mg, a pain management pharmaceutical. This competitive delivery order, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,847.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 100 mg on October 23, 2025, with completion targeted for October 24, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award is a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,070.28 to AmerisourceBergen Drug Corp for Nucynta Tabs 100mg, a prescription pain management medication. This competitively awarded, firm fixed-price contract was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $1,532.24 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 50 mg, a narcotic pain management medication. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,531.10 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, a prescription opioid pain management medication. The award, made on May 20, 2025, with completion targeted for May 21, 2025, utilized firm fixed price contracting with no set-aside designation, indicating competitive award procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,670.65 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, an extended-release opioid pain medication. This non-set-aside, firm fixed-price delivery order was awarded on August 29, 2025, with an ultimate completion date of September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on October 27, 2025, for Nucynta 75 mg tablets (100 count) with a ceiling value of $2,148.54 under a firm fixed-price contract. This is a non-set-aside award delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- SPE2DR25D2204Indefinite Delivery Contract
- SPE2DR25D2204-SPE2DR26FS19DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,805.53 to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 100 mg, a opioid pain management medication. This non-set-aside, firm fixed-price delivery order was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military and federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering a broad spectrum of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. All of AmerisourceBergen's reviewed contract awards with the DLA have been competitively awarded and non-set-aside, reflecting the company's ability to meet federal procurement requirements through open competition and maintain consistent delivery across transaction values ranging from under $100 to over $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/4/25 |